Melan-A, MART-1 (26-35) – 1 mg

Overview

Melan-A, MART-1 (26-35) is a crucial peptide in melanoma research, recognized as an immunodominant antigen derived from the melanocyte/melanoma (Melan-A/MART) protein. This decapeptide is particularly significant because it is more efficiently recognized by tumor-infiltrating lymphocytes (TILs) in melanoma patients compared to other variants, such as Melan-A (27-35). Its unique properties make it an essential tool for those studying tumor responses, immunology, and potential therapeutic strategies.

Key Features

• Immunodominant antigen from melanocyte/melanoma protein
• Recognized by tumor-infiltrating lymphocytes (TILs)
• Enhanced recognition compared to other peptide variants
• Available in a 1 mg vial for convenient research use
• Useful for melanoma research and immune response studies

Specifications

FAQ

What is the significance of the Melan-A, MART-1 (26-35) peptide?

This peptide plays a vital role in immunology, specifically in understanding how TILs recognize melanoma cells, which can lead to more effective treatments.

How should I store Melan-A, MART-1 (26-35) peptide?

Store the peptide at -20°C to maintain its stability and efficacy for extended periods. Protect it from light and moisture to prevent degradation.

Can I use this peptide for vaccine development?

Yes, Melan-A, MART-1 (26-35) is often utilized in vaccine research aimed at stimulating an immune response against melanoma.

For reliable results in your research, consider pairing Melan-A, MART-1 (26-35) with our other PKG Substrate or explore our extensive range of peptides to enhance your studies. Get your Melan-A, MART-1 (26-35) today and advance your research on melanoma and immunology.

Related Products

• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled